Inhibition of granulocyte-derived proteases reduces the increase in plasma endothelin associated with myocardial ischemia in the pig

Basic Research in Cardiology

Volumn 91, Issue 4, 1996, Pages 289-295

  Tonnessen T ^a   Ilebekk, A ^a   Naess, P A ^a   Christensen, G ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Eglin C; Endothelin; Granulocytes; Ischemia; Proteases

Indexed keywords

CATHEPSIN G; CHYMOTRYPSIN; EGLIN C; ELASTASE; ENDOTHELIN; PROTEINASE; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GRANULOCYTE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; SWINE;

EID: 0029762073     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00789301     Document Type: Article

References (29)

1. Froeschle MC, Goetz WA (eds) (1985) Elastase - a new marker for inflammatory diseases. GIT Verlag Darmstadt, pp 1-44
2. Grover GJ, Dzwonczyk S, Parham CS (1993) The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 27: 1613-1618
3. Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78: 225-228
4. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988) Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch 413: 108-110
5. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69: 209-215
6. Kaw S, Hecker M, Vane JR (1992) The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 89: 6886-6890
7. Kelly RA, Eid H, Kramer BK, O'Neill M, Liang BT, Reers M, Smith TW (1990) Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest 86: 1164-1171
8. Kusumoto K, Awane Y, Fujiwara S, Watanabe T (1993) Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 22 Suppl 8: S339-S342
9. A receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat. Pharmacology 49: 319-324
10. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr (1991) Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1808-1814
11. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T (1989) Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2: 53-54
12. Morita T, Kurihara H, Yoshizumi M, Maemura K, Sugiyama T, Nagai R, Yazaki Y (1993) Human polymorphonuclear leukocytes have dual effects on endothelin-1: the induction of endothelin-1 mRNA expression in vascular endothelial cells and modification of the endothelin-1 molecule. Heart Vessels 8: 1-6
13. Offstad J, Tønnessen T, Kirkebøen KA, Ilebekk A, Downing SE (1995) Modulation of systolic and diastolic function by endothelin-1: Relation to coronary flow. Acta Physiol Scand 154: 103-111
14. Patrignani P, Del Maschio A, Bazzoni G, Daffonchio L, Hernandez A, Modica R, Montesanti L, Volpi D, Patrono C, Dejana E (1991) Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes. Blood 78: 2715-2720
15. Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH (1989) Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet 2: 747
16. Sawamura T, Kimura S, Shinmi O, Sugita Y, Kobayashi M, Mitsui Y, Yanagisawa M, Goto K, Masaki T (1990) Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cells. Biochem Biophys Res Commun 169: 1138-1144
17. Schnebli HP, Seemüller U, Fritz H, Maschler R, Liersch M, Virca GD, Bodmer JL, Snider GL, Lucey EC, Stone PG (1985) Eglin C, a pharmacologically active elastase inhibitor. Eur J Respir Dis 66, Suppl 139: 66-70
18. Seemüller U, Meier M, Ohlsson K, Müller HP, Fritz H (1977) Isolation and characterization of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe Seyler's Z Physiol Chem 358: 1105-1117
19. Sessa WC, Kaw S, Hecker M, Vane JR (1991) The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 174: 613-618
20. Siebeck M, Hoffmann H, Jochum M, Fritz H (1989) Inhibition of proteinases with recombinant eglin c during experimental escherichia coli septicemia in the pig. Eur Surg Res 21: 11-17
21. Stawski G, Bang Olsen U, Grande P (1991) Cytotoxic effect of endothelin-1 during 'simulated' ischemia in cultured rat myocytes. Eur J Pharmacol 201: 123-124
22. Tsuji S, Sawamura A, Watanabe H, Takihara K, Park SE, Azuma J (1991) Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci 48: 1745-1749
23. Tønnessen T, Giaid A, Saleh D, Naess PA, Yanagisawa M, Christensen G (1995) Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 76: 767-772
24. Tønnessen T, Naess PA, Kirkebøen KA, Offstad J, Ilebekk A, Christensen G (1993) Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res 27: 1482-1485
25. Tønnessen T, Schlichting E, Lyberg T, Christensen G (1995) Inhibition of granulocyte-derived proteases abolishes endothelin-1 release and reduces mortality associated with intestinal ischemia and reperfusion in the pig. Endothelium 3: 225-234
26. Uprichard ACG, Chi L, Lucchesi BR (1993) Functional consequence of big endothelin conversion: Demonstration with isolated neutrophils but not in a postinfarction model. Pharmacology 47: 277-285
27. Wang QD, Li XS, Lundberg JM, Pernow J (1995) Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc Res 29: 805-812
28. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A (1993) Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69: 370-377
29. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415